Lung cancer
Conditions
Interventions
experimental group:Shuanghuang Shengbai Oral Liquid
control group:leucogen Tablets
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) non small cell lung cancer patients diagnosed by pathology or cytology, and researcher think it is suitable for use of pemetrexed combined with carboplatin (PC) regimen; (2) male and female aged 18~75 years old; (3) ECOG physical status score less than 2 points; (4) peripheral blood cell counts were in accordance with the conditions of chemotherapy : white blood cell count over 4 * 109/L, neutrophil count over 2 * 10^9/L; (5) liver function indexes ALT, TBIL and AST were all within 2.5 times of the upper normal limit; (6) renal function index: Cr in the upper limit of the normal value; (7) patients with expected survival of more than 3 months; (8) voluntarily signed written informed consent.
Exclusion criteria
Exclusion criteria: (1) received radiation therapy in the first 4 weeks of the group (2) the existing serious acute infection, and there is no control; or suppurative and chronic infection, wound healing; serious disease of heart, liver, kidney and hematopoietic system; (3) severe mental or neurological disorders affecting informed consent and / or adverse reactions; (3) to participate in other clinical trials in the first 4 months of this trial; (5) suspected of drug abuse, drug abuse, alcoholism; (6) allergies or allergic history of drugs and ingredients; (7) pregnant or lactating women or pregnant women may be pregnant before the first pregnancy test positive; (8) the researchers think that other subjects who are not suitable for the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and extent of leukocyte reduction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of leukocyte reduction;TCM syndrome score;Quality of life score;Dosage of recombinant human granulocyte colony stimulating factor (rhG-CSF); | — |
Countries
China
Contacts
Public ContactZhongqi Wang
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed